Advertisement

Topics

Clinical Ligand Assay Society's Company Profile

18:20 EDT 17th June 2018 | BioPortfolio

The Clinical Ligand Assay Society's mission is to establish and promote high standards in the science and application of ligand assay technology by encouraging research, educating practitioners, and fostering communication and cooperation among individuals in laboratories, in medicine, in academia and industry. Clinical Ligand Assay Society Goals
Ligand Assay Technology
To maintain an organization focused on the diagnostic, therapeutic, analytical and investigative use of ligand tehcnology assays and related methods.
To expand ligand assay technology by promoting education, encouraging basic and clinical research and advancing the practice of ligand assay as applied to biochemical, medical, pharmaceutical, veterinary, agricultural, environmental and industrial sciences.
To sponsor a national meeting, scientific symposia, review course, certification programs, workshops and publications which increase the understanding of ligand assay technology development and application.
To promote cooperation and mutual consultation among members working in laboratories, clinics, hospitals, educational institutions and industry.

Chapter Goals of
Clinical Ligand Assay Society New England

To provide the best educational events in the ligand field.
To provide several networking opportunities during the year.
To work directly with other societies and organizations in planning educational events. Northeast Region Conference is our pre-eminent meeting

Contact

Phone: 508-856-6003
Fax: 508-856-1095
Email: achase739@aol.com


News Articles [1434 Associated News Articles listed on BioPortfolio]

Impairment of Fas-ligand–caveolin-1 interaction inhibits Fas-ligand translocation to rafts and Fas-ligand-induced cell death

DNA Footprinting

Studying DNA–protein interactions is an important aspect of molecular biology. Researches use a variety of methods to study these like the chromatin immunoprecipitation (ChIP) assay, electrophoretic...

Luminex starts clinical trials for VERIGENE II gastrointestinal assay

Luminex has started clinical studies for the gastrointestinal (GI) assay on the VERIGENE II system.

Ooivant Licenses Diabetes Drug From Ligand Pharma

Ligand Pharmaceuticals is licensing LGD-6972, a glucagon receptor antagonist (GRA), to Roivant Sciences for $20 million.

ASCO 2018 conference round up

Dr Bishal Gyawali and Will Davies speak at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting about the highlights from this year's conference. - Dr Joseph Sparano spoke with ecance...

Screening Assay

Product AnnouncementAMSBIO's PARPtrap Assay Kit is designed to measure PARP1/DNA complex formation in a high throughput screening assay using fluorescence polarization.

Roivant Licenses Diabetes Drug From Ligand Pharma

Ligand Pharmaceuticals is licensing LGD-6972, a glucagon receptor antagonist (GRA), to Roivant Sciences for $20 million.

Ligand Pharmaceuticals Inc Q4 Income Climbs

WASHINGTON (dpa-AFX) - Ligand Pharmaceuticals Inc (LGND) released a profit for its fourth quarter that increased from last year.The company said its bottom line climbed to $29.63 million, or $1.31...

PubMed Articles [5711 Associated PubMed Articles listed on BioPortfolio]

A European multicenter study on the analytical performance of the VERIS HBV assay.

Hepatitis B viral load monitoring is an essential part of managing patients with chronic Hepatits B infection. Beckman Coulter has developed the VERIS HBV Assay for use on the fully automated Beckman ...

Performance evaluation of the Aptima HSV-1 and 2 assay for the detection of HSV in cutaneous and mucocutaneous lesion specimens.

Timely and precise laboratory diagnosis of Herpes simplex viruses (HSV) is required to guide clinical management.

Dependence receptors: the dark side awakens.

Transmembrane receptors are usually seen as on and off switch: when the specific ligand is bound, the receptor is on and transduces a downstream signal, while when the ligand is absent, the receptor i...

Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection.

Assays that detect HIV antigen (Ag) and antibody (Ab) can be used to screen for HIV infection.

X-Ray Structures of Target-Ligand Complexes Containing Compounds with Assay Interference Potential.

Pan assay interference compounds (PAINS) have become a paradigm for compound classes that might cause artifacts in biological assays. PAINS-defining substructures are typically contained in larger com...

Clinical Trials [2751 Associated Clinical Trials listed on BioPortfolio]

Clinical Performance Evaluation of DxN CMV Assay

The DxN Cytomegalovirus (CMV) assay is an in vitro diagnostic assay intended as an aid in the management of CMV-infected individuals undergoing antiviral therapy. the purpose of the study ...

Clinical Performance Evaluation of AMH Assay

The Access AMH Assay is an in vitro diagnostic assay intended as an aid for fertility assessment. The purpose of the study is to evaluate the clinical performance of the Access AMH Assay i...

Clinical Evaluation of the QuantiFERON CMV Assay

Validate the use of the device in the clinical setting for assessing the risk of CMV Infection in SOT recipients after the completion of antiviral prophylaxis.

Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens

To assess and compare the performance of the HR HPV HC2® test (Qiagen/Digene) and the APTIMA® HPV Assay (Hologic) using LBC Specimens (ThinPrep® Pap Test) for the detection of HPV infec...

Clinical Evaluation of the PROGENSA(R) PCA3 Assay in Men With a Previous Negative Biopsy Result

The objective of this multi-center clinical study is to determine the association of the PCA3 Score with prostate biopsy outcome and validate the assay's performance characteristics in men...

Companies [2311 Associated Companies listed on BioPortfolio]

Clinical Ligand Assay Society's

The Clinical Ligand Assay Society's mission is to establish and promote high standards in the science and application of ligand assay technology by encouraging research, educating practitioners, and f...

Clinical Ligand Assay Society

MISSION The Clinical Ligand Assay Society mission is to establish and promote high standards in the science and application of ligand assay technology by encouraging research, educating practitione...

BioAnalab Ltd

BioAnaLab is a leading CRO specialising in analysis of biological therapeutics. We use ligand binding and cell based assays for toxicokinetic/pharmacokinetic and pharmacodynamic analysis, immunopheno...

Ligand Pharmaceuticals

Ligand is an emerging specialty pharmaceutical company that discovers, develops and markets innovative small molecule drugs to address critical, unmet medical needs. Ligand markets four oncology and d...

Ligand Pharmaceuticals Incorporated

Ligand discovers and develops new drugs that address critical unmet medical needs of patients for a broad spectrum of diseases including hepatitis, muscle wasting, Alzheimer's, in...

More Information about "Clinical Ligand Assay Society's" on BioPortfolio

We have published hundreds of Clinical Ligand Assay Society's news stories on BioPortfolio along with dozens of Clinical Ligand Assay Society's Clinical Trials and PubMed Articles about Clinical Ligand Assay Society's for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Clinical Ligand Assay Society's Companies in our database. You can also find out about relevant Clinical Ligand Assay Society's Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...


Corporate Database Quicklinks



Searches Linking to this Company Record